Suzhou Basecare Medical (HKSE:02170) Debt-to-Equity : 0.20 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical Debt-to-Equity?

Suzhou Basecare Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$16.6 Mil. Suzhou Basecare Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$291.7 Mil. Suzhou Basecare Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,530.4 Mil. Suzhou Basecare Medical's debt to equity for the quarter that ended in Dec. 2023 was 0.20.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Suzhou Basecare Medical's Debt-to-Equity or its related term are showing as below:

HKSE:02170' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.06 Med: 0.04 Max: 0.2
Current: 0.2

During the past 6 years, the highest Debt-to-Equity Ratio of Suzhou Basecare Medical was 0.20. The lowest was -0.06. And the median was 0.04.

HKSE:02170's Debt-to-Equity is ranked better than
51.79% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs HKSE:02170: 0.20

Suzhou Basecare Medical Debt-to-Equity Historical Data

The historical data trend for Suzhou Basecare Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical Debt-to-Equity Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.04

0.11

0.03

0.05

0.20

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial					0.03	0.03	0.05	0.15	0.20

Competitive Comparison of Suzhou Basecare Medical's Debt-to-Equity

For the Medical Devices subindustry, Suzhou Basecare Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's Debt-to-Equity falls into.

Suzhou Basecare Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Suzhou Basecare Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16.61	+	291.745)	/	1530.389
	=	0.20

Suzhou Basecare Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16.61	+	291.745)	/	1530.389
	=	0.20

Suzhou Basecare Medical (HKSE:02170) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Suzhou Basecare Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical (HKSE:02170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines